384 related articles for article (PubMed ID: 16053668)
1. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.
Fury MG; Antonescu CR; Van Zee KJ; Brennan MF; Maki RG
Cancer J; 2005; 11(3):241-7. PubMed ID: 16053668
[TBL] [Abstract][Full Text] [Related]
2. The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
Chen TW; Pang A; Puhaindran ME; Maw MM; Loong HH; Sriuranpong V; Chang CC; Mingmalairak S; Hirose T; Endo M; Kawai A; Farid M; Tan SH; Goh WL; Quek R; Chan JCH; Leung AKC; Ngan RKC
Cancer Sci; 2021 Mar; 112(3):1095-1104. PubMed ID: 33393133
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of taxane regimens in patients with metastatic angiosarcoma.
Hirata T; Yonemori K; Ando M; Hirakawa A; Tsuda H; Hasegawa T; Chuman H; Namikawa K; Yamazaki N; Fujiwara Y
Eur J Dermatol; 2011; 21(4):539-45. PubMed ID: 21697045
[TBL] [Abstract][Full Text] [Related]
4. [Single-center study of different treatment for advanced or unresectable angiosarcoma patients].
Peng RQ; Xu BS; Liu YY; Yang QQ; Pan QZ; Zhang X
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):74-81. PubMed ID: 36709123
[No Abstract] [Full Text] [Related]
5. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Oashi K; Shibata T; Namikawa K; Takahashi A; Yokota K; Nakano E; Teramoto Y; Tsutsumida A; Maeda T; Yamazaki N;
BMC Cancer; 2020 Jul; 20(1):652. PubMed ID: 32660439
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
[TBL] [Abstract][Full Text] [Related]
7. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics and outcomes of primary angiosarcoma].
Zhang ZY; Cheng YJ; Gong XL; Ge YP; Bai CM; Wang XJ; Miao Q; Zhang FQ
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):693-697. PubMed ID: 31550860
[No Abstract] [Full Text] [Related]
9. Angiosarcomas and taxanes.
Penel N; Lansiaux A; Adenis A
Curr Treat Options Oncol; 2007 Dec; 8(6):428-34. PubMed ID: 18066504
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
Skubitz KM; Haddad PA
Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
[TBL] [Abstract][Full Text] [Related]
12. Angiosarcoma of the breast: a difficult surgical challenge.
Hui A; Henderson M; Speakman D; Skandarajah A
Breast; 2012 Aug; 21(4):584-9. PubMed ID: 22305554
[TBL] [Abstract][Full Text] [Related]
13. Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.
Park C; Kim M; Kwak Y; Moon KC; Kim SH; Keam B; Kim YJ; Kim TM; Kim DW
Cancer Res Treat; 2021 Oct; 53(4):1195-1203. PubMed ID: 33540493
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
15. Congenital angiosarcoma with transient response to paclitaxel.
Good AB; Nascimento A; Welker KM; Arndt CA
J Pediatr Hematol Oncol; 2008 Jun; 30(6):451-3. PubMed ID: 18525462
[TBL] [Abstract][Full Text] [Related]
16. Angiosarcoma of the face and scalp: effective systemic treatment in the older patient.
Letsa I; Benson C; Al-Muderis O; Judson I
J Geriatr Oncol; 2014 Jul; 5(3):276-80. PubMed ID: 24685486
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over.
Paridaens R; Biganzoli L; Bruning P; Klijn JG; Gamucci T; Houston S; Coleman R; Schachter J; Van Vreckem A; Sylvester R; Awada A; Wildiers J; Piccart M
J Clin Oncol; 2000 Feb; 18(4):724-33. PubMed ID: 10673513
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.
Kajihara I; Kanemaru H; Miyake T; Aoi J; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2015 Feb; 9(1):75-7. PubMed ID: 25788055
[TBL] [Abstract][Full Text] [Related]
19. Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions.
Palmerini E; Maki RG; Staals EL; Alberghini M; Antonescu CR; Ferrari C; Ruggieri P; Mavrogenis A; Bertoni F; Cesari M; Paioli A; Marchesi E; Picci P; Ferrari S
Am J Clin Oncol; 2014 Dec; 37(6):528-34. PubMed ID: 23466575
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Angiosarcoma: Clinical and Pathology Study of 16 Cases.
Requena C; Sendra E; Llombart B; Sanmartín O; Guillén C; Lavernia J; Traves V; Cruz J
Actas Dermosifiliogr; 2017 Jun; 108(5):457-465. PubMed ID: 28318524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
